PBI Gordon Names Santosuosso As PRN® Pharmacal General ManagerAnimal Health Industry Veteran to Lead Company

(Pensacola, Fla. ” February 18, 2013) ” PBI-Gordon Corporation, parent company of Pegasus Laboratories, makers of PRN® Pharmacal branded products, has named animal health industry veteran Jeff Santosuosso as Vice President – General Manager. Santosuosso previously was Director of Sales & Marketing of PRN Pharmacal.

As Vice President-General Manager, Santosuosso leads a team in Accounting/Administration, Operations, R&D/Compliance, Marketing and Sales, Contract Manufacturing and Business Development to achieve short- and long-term goals. Upon announcing the appointment, Don Chew, President and Chief Executive Officer of PBI-Gordon Corporation said,

“Since joining the company, Jeff has quickly embraced the culture of the company and led his team with an industry knowledge and commitment to the veterinary profession second to none. I believe he will be highly successful in this new leadership role as well.”

Prior to joining Pegasus, Santosuosso was Vice President of Business Development at Virbac Corporation from 2005 to 2012. He served as Director of Marketing at Virbac from 2000 to 2004. Prior to joining Virbac, Santosuosso was Marketing Manager at Novartis Crop Protection. He began his career in animal health as a Marketing Manager at Merck.

“I am grateful for the opportunity to lead a company poised for substantial growth. It is an exciting time at Pegasus and I look forward to focusing attention on our manufacturing operations and continuing to build and lead a dynamic team to successfully meet our goals and objectives,” said Santosuosso.Santosuosso received his Master’s of Business Administration degree from the Tuck School of Business at Dartmouth. He earned his Bachelor of Arts degree from Stanford University.

Pegasus Laboratories manufactures products which are distributed and marketed to the veterinary profession under the name PRN Pharmacal. Brand names include PROIN® for canine urinary incontinence and the newly introduced Collasate Silver® gel to its line of wound care treatment products among others. To learn more about PRN Pharmacal products, visit www.PRNPharmacal.com or call 1-800-874-9764.

Related Press Releases:

PRN® Pharmacal Introduces Collasate® Silver Gel

Lifetime’s “Designing Spaces of Hope – Adopts a Shelter” TV Segment Features Dr. Marisa Shulman Discussing PROIN (phenylpropanolamine hydrochloride) & Canine Urinary Incontinence

Click on the Logo Above to View The Designing Pet Spaces Segment

It Will Air On Lifetime March 21, 2013


Comments are closed.